Columbia scientists reveal new details of how a naturally occurring hormone can boost memory in aging mice, laying the groundwork for staving off this form of memory loss in people.
By determining the molecular signatures of Alzheimer’s, CTE and other conditions, Anthony Fitzpatrick and his research team to pave way for treatments that target hallmarks of neurodegenerative disease.
Academy recognizes decades of work to map complex pathways that connect the eye to the brain; research that could inform treatments of developmental and vision disorders.
New study in mice shows how the brain learns to reproduce patterns of brain activity that lead to reward; provides insights for treating addiction and obsessive-compulsive disorder.
A new study in mice suggests that a burst of dopamine levels at the beginning of a movement only, as opposed to all the time, is what gets us going. This may have important implications for treating Parkinson’s disease.
Series of awards unites experts from different fields and universities; bolsters innovative, team approach to deciphering the complexities of the brain.
Single-cell atlas will serve to guide precise strategies for understanding and treating spinal-cord disease and injury, and is part of Initiative’s larger Human Cell Atlas project.
A new study in mice reveals that one of the body’s natural defenses against ALS suppresses disease progression early on, but in later stages advances the disease’s deadly spread through the spinal cord.
New study in mice reveals biological origins of memory deficits, a core symptom of schizophrenia.
Twin papers lend clues into how the brain organizes itself, offering new avenues for studying psychiatric disorders.
